MicroRNA-497 impairs the growth of chemoresistant neuroblastoma cells by targeting cell cycle, survival and vascular permeability genes

Aroa Soriano, Laia París-Coderch, Luz Jubierre, Alba Martínez, Xiangyu Zhou, Olga Piskareva, Isabella Bray, Isaac Vidal, Ana Almazán-Moga, Carla Molist, Josep Roma, José R. Bayascas, Oriol Casanovas, Raymond L. Stallings, José Sánchez de Toledo, Soledad Gallego, Miguel F. Segura*

*Corresponding author for this work

Research output: Contribution to journalArticleResearchpeer-review

19 Citations (Scopus)

Abstract

Despite multimodal therapies, a high percentage of high-risk neuroblastoma (NB) become refractory to current treatments, most of which interfere with cell cycle and DNA synthesis or function, activating the DNA damage response (DDR). In cancer, this process is frequently altered by deregulated expression or function of several genes which contribute to multidrug resistance (MDR). MicroRNAs are outstanding candidates for therapy since a single microRNA can modulate the expression of multiple genes of the same or different pathways, thus hindering the development of resistance mechanisms by the tumor. We found several genes implicated in the MDR to be overexpressed in high-risk NB which could be targeted by microRNAs simultaneously. Our functional screening identified several of those microRNAs that reduced proliferation of chemoresistant NB cell lines, the best of which was miR-497. Low expression of miR-497 correlated with poor patient outcome. The overexpression of miR-497 reduced the proliferation of multiple chemoresistant NB cell lines and induced apoptosis in MYCN-amplified cell lines. Moreover, the conditional expression of miR-497 in NB xenografts reduced tumor growth and inhibited vascular permeabilization. MiR-497 targets multiple genes related to the DDR, cell cycle, survival and angiogenesis, which renders this molecule a promising candidate for NB therapy.

Original languageAmerican English
Pages (from-to)9271-9287
Number of pages17
JournalOncotarget
Volume7
Issue number8
DOIs
Publication statusPublished - 2016

Keywords

  • Epigenetic therapy
  • MicroRNA
  • Neuroblastoma
  • Vascular permeability

Fingerprint Dive into the research topics of 'MicroRNA-497 impairs the growth of chemoresistant neuroblastoma cells by targeting cell cycle, survival and vascular permeability genes'. Together they form a unique fingerprint.

Cite this